NEXI (OTC)
NEXIMMUNE INC
$0.000100
+0.000000 (+0.00%)
Prev close: $0.000100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Kristi Jones
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.00M
- Employees
- 50
- P/E (TTM)
- -0.09
- P/B (TTM)
- 0.34
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $1.01M |
| Operating Expenses | $21.63M |
| Research and Development | $9.67M |
| Other Operating Expenses | $11.96M |
| Operating Income/Loss | -$21.63M |
| Income/Loss From Continuing Operations After Tax | -$20.62M |
| Income/Loss From Continuing Operations Before Tax | -$15.63M |
| Income Tax Expense/Benefit | $4.98M |
| Net Income/Loss | -$20.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.62M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$18.50 |
| Diluted Earnings Per Share | -$18.50 |
| Basic Average Shares | 2,368,053 |
| Diluted Average Shares | 2,368,053 |
| Assets | $5.86M |
| Current Assets | $3.13M |
| Noncurrent Assets | $2.73M |
| Fixed Assets | $1.11M |
| Other Non-current Assets | $1.63M |
| Liabilities | $4.94M |
| Current Liabilities | $4.74M |
| Accounts Payable | $1.28M |
| Wages | $351.06K |
| Other Current Liabilities | $3.10M |
| Noncurrent Liabilities | $204.17K |
| Equity | $696.35K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $696.35K |
| Temporary Equity | $224.19K |
| Temporary Equity Attributable To Parent | $224.19K |
| Liabilities And Equity | $5.86M |
| Net Cash Flow From Operating Activities | -$17.61M |
| Net Cash Flow From Operating Activities, Continuing | -$17.61M |
| Net Cash Flow From Investing Activities | $569.38K |
| Net Cash Flow From Investing Activities, Continuing | $569.38K |
| Net Cash Flow From Financing Activities | $16.26M |
| Net Cash Flow From Financing Activities, Continuing | $16.26M |
| Net Cash Flow | -$778.34K |
| Net Cash Flow, Continuing | -$778.34K |
| Comprehensive Income/Loss | -$20.62M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.62M |
| Other Comprehensive Income/Loss | -$15.21M |